Opportunity Information: Apply for RFA AG 20 030
The National Institutes of Health (NIH) funding opportunity titled "Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-AG-20-030; CFDA 93.866) supports research projects that examine how the microbiome changes across the aging process and how those changes may contribute to health outcomes in older adults. The focus is on understanding both the composition of microbial communities (which organisms are present) and their functional characteristics (what they are doing biologically), with an emphasis on identifying the drivers of microbiome shifts during aging and clarifying how those shifts intersect with the development and progression of age-related chronic diseases.
A central goal of the FOA is to move beyond simple descriptions of age-related microbiome differences and into more explanatory, mechanism-oriented science. Projects are encouraged to define factors that shape the aging microbiome, which can include host biology, immune and metabolic changes, medications, diet, environment, and other exposures that accumulate or change with age. The FOA also seeks studies that connect microbiome alterations to the causes and pathophysiology of chronic conditions common in later life, meaning applicants should aim to explain plausible biological pathways through which microbiome features influence disease onset, severity, or progression rather than treating the microbiome as a stand-alone observational finding.
In addition to mechanistic understanding, the FOA explicitly invites research aimed at developing and testing targeted microbiome-relevant interventions. These interventions can include dietary approaches, drug-based strategies, or the use of live organisms (for example, probiotics or other microbial therapeutics), as long as the work fits within the non-clinical-trial boundaries of the announcement. The intent is to support research that can identify actionable levers for shifting microbiome function or composition in ways that may promote healthier aging or reduce disease risk, while still remaining within the allowable study designs under "Clinical Trial Not Allowed."
In terms of study types, the FOA permits basic mechanistic research and preclinical studies in animal models, which can be used to test causality, dissect pathways, and evaluate interventions under controlled conditions. It also allows human research that leverages existing human longitudinal cohorts, emphasizing the value of repeated measures over time to understand how microbiome features evolve with aging and how those trajectories relate to later health outcomes. The emphasis on existing cohorts signals that the FOA is designed to capitalize on established longitudinal resources rather than launching new clinical trials or large new prospective enrollment efforts under this mechanism.
The award mechanism is an R01 research project grant under the NIH discretionary grant category in health. The original closing date listed for the opportunity was October 30, 2019, and the posting date (creation date) was July 23, 2019. Specific values for an award ceiling and expected number of awards are not provided in the source data shown.
Eligibility is broad and includes many common domestic applicant categories such as state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories as specified); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also highlights additional eligible applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, and U.S. territories or possessions.
At the same time, the FOA places strict limits on foreign involvement. Non-domestic (non-U.S.) institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined in the NIH Grants Policy Statement are not allowed. In practical terms, applicants need to ensure the applicant organization is U.S.-based and that the proposed work does not include foreign components that would violate these restrictions.
Overall, this FOA is designed for research teams aiming to clarify how aging reshapes the microbiome, why those changes happen, how they relate to the biology of chronic diseases of aging, and how targeted non-clinical-trial interventions might modify microbiome-related mechanisms to improve health in older populations.Apply for RFA AG 20 030
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-07-23.
- Applicants must submit their applications by 2019-10-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: NEA Sound Health Network, FY2020
Previous opportunity: FY2020 English Language Teacher Training Project
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 030
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 030) also looked into and applied for these:
| Funding Opportunity |
|---|
| Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21) Apply for RFA AT 20 001 Funding Number: RFA AT 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 19 328 Funding Number: PAR 19 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 19 329 Funding Number: PAR 19 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 19 330 Funding Number: PAR 19 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required Apply for PAR 19 335 Funding Number: PAR 19 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 044 Funding Number: RFA AG 20 044 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional) Apply for PAR 19 337 Funding Number: PAR 19 337 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Community Health and Nutrition Apply for 72027819RFA00001 Funding Number: 72027819RFA00001 Agency: Agency for International Development Category: Health Funding Amount: $19,700,000 |
| Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) Apply for PAR 19 338 Funding Number: PAR 19 338 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional) Apply for PAR 19 344 Funding Number: PAR 19 344 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 19 342 Funding Number: PAR 19 342 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed) Apply for PAR 19 343 Funding Number: PAR 19 343 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Apply for PAR 19 346 Funding Number: PAR 19 346 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) Apply for PAR 19 347 Funding Number: PAR 19 347 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) Apply for PAR 19 351 Funding Number: PAR 19 351 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER) Apply for 72061219RFA00005 Funding Number: 72061219RFA00005 Agency: Malawi USAID-Lilongwe Category: Health Funding Amount: $33,000,000 |
| Health Workforce Improvement Program (HWIP) Apply for 72066319RFA00005 Funding Number: 72066319RFA00005 Agency: Ethiopia USAID-Addis Ababa Category: Health Funding Amount: $39,500,000 |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional) Apply for RFA RM 19 013 Funding Number: RFA RM 19 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) Apply for PAR 19 364 Funding Number: PAR 19 364 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) Apply for PAR 19 362 Funding Number: PAR 19 362 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 030", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
